Cargando…
Myelinating Glia: Potential Therapeutic Targets in Polyglutamine Spinocerebellar Ataxias
Human studies, in combination with animal and cellular models, support glial cells as both major contributors to neurodegenerative diseases and promising therapeutic targets. Among glial cells, oligodendrocytes and Schwann cells are the myelinating glial cells of the central and peripheral nervous s...
Autores principales: | Putka, Alexandra F., Mato, Juan P., McLoughlin, Hayley S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953858/ https://www.ncbi.nlm.nih.gov/pubmed/36831268 http://dx.doi.org/10.3390/cells12040601 |
Ejemplares similares
-
Pathogenetic Mechanisms Underlying Spinocerebellar Ataxia Type 3 Are Altered in Primary Oligodendrocyte Culture
por: Schuster, Kristen H., et al.
Publicado: (2022) -
Disease-associated oligodendrocyte signatures are spatiotemporally dysregulated in spinocerebellar ataxia type 3
por: Schuster, Kristen H., et al.
Publicado: (2023) -
Genetics, Mechanisms, and Therapeutic Progress in Polyglutamine Spinocerebellar Ataxias
por: Buijsen, Ronald A.M., et al.
Publicado: (2019) -
The Mechanisms of Nuclear Proteotoxicity in Polyglutamine Spinocerebellar Ataxias
por: Lee, Davin, et al.
Publicado: (2020) -
Functional implications of paralog genes in polyglutamine spinocerebellar ataxias
por: Felício, Daniela, et al.
Publicado: (2023)